The distribution and expression of claudin-5 and occludin at the rat blood-optic nerve barrier after borneol treatment
- PMID: 20473716
- DOI: 10.1007/s11033-010-0184-1
The distribution and expression of claudin-5 and occludin at the rat blood-optic nerve barrier after borneol treatment
Abstract
The purpose of this study is to investigate the distribution and expression of the tight junction membrane proteins, claudin-5 and occludin, in rat blood-optic nerve barrier after borneol treatment. Seventy-two female Wistar rats were randomly divided into the borneol gastric lavage group and the equal volume solvent gastric lavage control group. The bilateral optic nerve from the retrobulbar region to the optic chiasma was collected from the rats in the two groups before gastric lavage and at 30 min, 1, 2, 4, and 8 h after gastric lavage. The distribution and expression of claudin-5 and occludin were detected using immunofluorescence staining, Western blotting, and reverse transcription polymerase chain reaction (RT-PCR). Results showed that claudin-5 translocated from the cell membrane to the cytoplasm at 30 min following initiation of borneol treatment, and this translocation peaked at 1 h. During this period of time, a small amount of occludin also translocated from the cell membrane to the cytoplasm. Four hours after initiation of treatment, claudin-5 and occludin levels in the cytoplasm began to decrease and were restored to their normal pattern 8 h after initiation of treatment. There were no significant differences in the levels of claudin-5 or occludin before or after treatment in either group. It was concluded that claudin-5 and occludin translocate within cells of the rat blood-optic nerve barrier after borneol treatment, and this translocation was reversible. Claudin-5 may play a potential role in permeability of the blood-optic nerve barrier following borneol treatment.
Similar articles
-
Regional differences in blood-nerve barrier function and tight-junction protein expression within the rat dorsal root ganglion.Neuroreport. 2004 Mar 1;15(3):405-8. doi: 10.1097/00001756-200403010-00004. Neuroreport. 2004. PMID: 15094492
-
Borneol increases blood-tumour barrier permeability by regulating the expression levels of tight junction-associated proteins.Pharm Biol. 2016 Dec;54(12):3009-3018. doi: 10.1080/13880209.2016.1199044. Epub 2016 Jul 18. Pharm Biol. 2016. PMID: 27431008
-
Ethanol-induced activation of myosin light chain kinase leads to dysfunction of tight junctions and blood-brain barrier compromise.Alcohol Clin Exp Res. 2005 Jun;29(6):999-1009. doi: 10.1097/01.alc.0000166944.79914.0a. Alcohol Clin Exp Res. 2005. PMID: 15976526
-
Immunolocalization of occludin and claudin-1 to tight junctions in intact CNS vessels of mammalian retina.J Neurocytol. 2001 Feb;30(2):107-23. doi: 10.1023/a:1011982906125. J Neurocytol. 2001. PMID: 11577249
-
Borneol in cardio-cerebrovascular diseases: Pharmacological actions, mechanisms, and therapeutics.Pharmacol Res. 2021 Jul;169:105627. doi: 10.1016/j.phrs.2021.105627. Epub 2021 Apr 21. Pharmacol Res. 2021. PMID: 33892091 Review.
Cited by
-
Recent Progress on the Synergistic Antitumor Effect of a Borneol-Modified Nanocarrier Drug Delivery System.Front Med (Lausanne). 2021 Nov 25;8:750170. doi: 10.3389/fmed.2021.750170. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34901063 Free PMC article. Review.
-
Drug Permeability: From the Blood-Brain Barrier to the Peripheral Nerve Barriers.Adv Ther (Weinh). 2023 Apr;6(4):2200150. doi: 10.1002/adtp.202200150. Epub 2023 Jan 18. Adv Ther (Weinh). 2023. PMID: 37649593 Free PMC article.
-
Borneol, a novel agent that improves central nervous system drug delivery by enhancing blood-brain barrier permeability.Drug Deliv. 2017 Nov;24(1):1037-1044. doi: 10.1080/10717544.2017.1346002. Drug Deliv. 2017. PMID: 28687052 Free PMC article.
-
Influence of Orally Administered Borneol on the Expression of Hepatic Transporters in Rats.Eur J Drug Metab Pharmacokinet. 2019 Feb;44(1):103-109. doi: 10.1007/s13318-018-0499-1. Eur J Drug Metab Pharmacokinet. 2019. PMID: 30105488
-
Preparation and evaluation of sustained-release solid dispersions co-loading gastrodin with borneol as an oral brain-targeting enhancer.Acta Pharm Sin B. 2014 Feb;4(1):86-93. doi: 10.1016/j.apsb.2013.12.012. Epub 2014 Jan 24. Acta Pharm Sin B. 2014. PMID: 26579369 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources